Salman T Qureshi Selected Research

Protollin

1/2017	The TLR4-TRIF pathway can protect against the development of experimental allergic asthma.
9/2012	ICOS-expressing CD4 T cells induced via TLR4 in the nasal mucosa are capable of inhibiting experimental allergic asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salman T Qureshi Research Topics

Disease

13	Infections 01/2021 - 03/2003
6	Inflammation (Inflammations) 08/2017 - 05/2012
4	Pneumonia (Pneumonitis) 12/2019 - 11/2010
4	Respiratory Hypersensitivity 01/2017 - 04/2013
4	Eosinophilia 01/2014 - 10/2008
3	Acute Lung Injury 01/2021 - 11/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 03/2015
3	Neoplasm Metastasis (Metastasis) 12/2019 - 03/2015
3	Asthma (Bronchial Asthma) 01/2014 - 04/2013
2	Lung Injury 05/2012 - 04/2006
1	Aspergillosis 01/2021
1	Neuroinflammatory Diseases 01/2019
1	Immune Reconstitution Inflammatory Syndrome 01/2019
1	Cryptococcosis 01/2017
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2016
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2016
1	Disease Progression 01/2016
1	Lung Neoplasms (Lung Cancer) 03/2015
1	Hyperplasia 09/2013
1	Metaplasia 12/2012
1	Obstructive Lung Diseases (Obstructive Lung Disease) 11/2010
1	Septic Shock (Toxic Shock Syndrome) 09/2010
1	Fibrosis (Cirrhosis) 07/2010
1	Hyperlipidemias (Hyperlipidemia) 09/2009
1	Atherosclerosis 09/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2009
1	Human Influenza (Influenza) 05/2008
1	Communicable Diseases (Infectious Diseases) 05/2008
1	Hyperoxia 04/2006

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2021 - 10/2008
6	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2019 - 03/2003
3	Toll-Like Receptor 2IBA 01/2017 - 07/2010
3	Interleukin-13IBA 12/2015 - 12/2012
3	Interleukin-5 (Interleukin 5)IBA 12/2015 - 12/2012
2	Toll-Like Receptor 4IBA 12/2019 - 03/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2010
2	ProtollinIBA 01/2017 - 09/2012
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2017 - 10/2008
2	Interferon-gamma (Interferon, gamma)IBA 12/2015 - 10/2008
2	Interleukin-4 (Interleukin 4)IBA 12/2015 - 10/2008
2	Interleukin-12 (IL 12)IBA 12/2015 - 10/2008
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 12/2012
2	ChemokinesIBA 04/2013 - 10/2008
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	Fungal PolysaccharidesIBA 08/2017
1	Polysaccharides (Glycans)IBA 08/2017
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 01/2017
1	Interleukin-1 Type I ReceptorsIBA 01/2017
1	CardiotoxinsIBA 05/2016
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 03/2015
1	EndotoxinsIBA 01/2014
1	OvalbuminIBA 01/2014
1	Immunoglobulin E (IgE)IBA 09/2013
1	AllergensIBA 07/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2013
1	1,3-dimethylthioureaIBA 07/2013
1	AntioxidantsIBA 07/2013
1	Oxidoreductases (Dehydrogenase)IBA 07/2013
1	Acetylcysteine (Siran)FDA LinkGeneric 07/2013
1	Interleukin-17 (Interleukin 17)IBA 04/2013
1	Transcription Factors (Transcription Factor)IBA 05/2012
1	TOR Serine-Threonine KinasesIBA 05/2012
1	Sirolimus (Rapamycin)FDA Link 05/2012
1	LipopolysaccharidesIBA 05/2012
1	Peptides (Polypeptides)IBA 09/2009
1	Lipoproteins (Lipoprotein)IBA 09/2009
1	LipidsIBA 09/2009
1	urotensin IIIBA 09/2009
1	Apolipoproteins E (ApoE)IBA 09/2009
1	Chemokine CCL4IBA 10/2008
1	Messenger RNA (mRNA)IBA 10/2008
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2008
1	Pharmaceutical PreparationsIBA 05/2008
1	PrionsIBA 05/2008
1	OzoneIBA 04/2006
1	Heme Oxygenase-1IBA 04/2006
1	Small Interfering RNA (siRNA)IBA 04/2006

Therapy/Procedure

1	Analgesia 01/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2019
1	Radiotherapy 07/2010
1	Intranasal Administration 04/2006